Medtronic
MDT
994 hedge funds and large institutions have $42B invested in Medtronic in 2013 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 351 increasing their positions, 420 reducing their positions, and 48 closing their positions.
46% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 48
1% more funds holding
Funds holding: 981 → 994 (+13)
10% more call options, than puts
Call options by funds: $262M | Put options by funds: $239M
3% more capital invested
Capital invested by funds: $40.9B → $42B (+$1.12B)
0.25% more ownership
Funds ownership: 78.9% → 79.15% (+0.25%)
16% less repeat investments, than reductions
Existing positions increased: 351 | Existing positions reduced: 420
23% less funds holding in top 10
Funds holding in top 10: 43 → 33 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$284M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$142M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$97.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$80.1M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$274M |
| 2 |
Bank of New York Mellon
New York
|
-$184M |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$109M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$88.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$85.5M |
MDT Hedge Fund Activity: Q3 2013 in Review
994 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2013, worth a combined $42B — up 2.7% from $40.9B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new MDT positions and 48 closed out — a net gain of 22 holders — while 351 added to existing stakes and 420 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $284M. The largest seller was Capital Research Global Investors, cutting an estimated $274M.
- 994 institutional investors held Medtronic (MDT) as of Q3 2013, up from 981 in Q2 2013.
- Funds reported $42B of Medtronic stock for Q3 2013, up 2.7% quarter-over-quarter.
- 70 funds opened new Medtronic positions in Q3 2013 and 48 closed out, a net change of +22 holders.
- The largest Medtronic buyer in Q3 2013 was OppenheimerFunds, an estimated $284M added.
- The largest Medtronic seller in Q3 2013 was Capital Research Global Investors, an estimated $274M sold.
Based on aggregated 13F filings for Q3 2013.